WASHINGTON — TECcare Ultra from Talley Environmental Care Ltd. has become the first and only product to pass the new and more stringent U.S. Environmental Protection Agency (EPA) approved testing protocol for killing Clostridium Difficile (C. diff) spores, according to a press release.
The EPA has posted guidelines for efficacy testing to obtain the C. diff sporicidal claim for hard, non-porous surfaces on their website: Http://www.epa.gov/oppad001/cdif-guidance.html, the release stated.
According to a survey conducted by the Association for Professionals in Infection Control and Epidemiology (APIC), 13 out of every 1,000 inpatients were either infected or colonized with C. diff, costing an estimated $17.6 to $51.5 million a year, the release noted.
Kevin Mearns, director of business development for Talley Environmental Care, said: "Passing these latest approved tests once again highlights the excellent efficacy of TECcare Ultra, and combined with its exceptional safety credentials, the product has been proven to kill this potentially life threatening pathogen. TECcare Ultra offers a true sporicidal product, one that does not contain damaging chemicals and skin irritants such as bleach, alcohols, phenols, chlorine and aldehydes and is well suited for repeated use on surfaces. It is safe and effective as well as fully biodegradable and environmentally friendly."
TECcare Ultra can be used in a variety of facilities, including: Health care; pharmaceuticals; foodservice; hospitality; schools and nurseries; and general hygiene applications, the release added.
Click here to read the complete release.
For related information, click here.